protein

Galectin-9/LGALS9 Protein, Human (HEK293, His)

HY-P70535

5 μg;10 μg;50 μg;100 μg

56;90;250;425 USD

Galectin-9/LGALS9 Protein, Human (HEK293, His)

proteins

HEK293

5 μg;10 μg;50 μg;100 μg

56;90;250;425 USD

Galectin-9/LGALS9 Protein acts as an eosinophil chemoattractant, recruiting and migrating eosinophils, key immune cells in inflammatory responses. It also serves as an angiogenesis inhibitor, regulating blood vessel formation and impacting vascular processes. Functioning as a regulatory modulator, Galectin-9/LGALS9 suppresses interferon-gamma (IFNG) production by natural killer cells, exerting control over immune signaling pathways. Galectin-9/LGALS9 Protein, Human (HEK293, His) is the recombinant human-derived Galectin-9/LGALS9 protein, expressed by HEK293 , with C-6*His labeled tag.

Human

Galectin-9/LGALS9 protein functions as an eosinophil chemoattractant, actively participating in the recruitment and migration of eosinophils, crucial immune cells involved in inflammatory responses. Moreover, it serves as an angiogenesis inhibitor, contributing to the regulation of blood vessel formation and impacting vascular processes. In its role as a regulatory modulator of immune responses, Galectin-9/LGALS9 suppresses interferon-gamma (IFNG) production by natural killer cells, exerting control over immune signaling pathways (By similarity).

Galectin-9; Gal-9; Ecalectin; Tumor Antigen HOM-HD-21; LGALS9

Greater than 95% as determined by reducing SDS-PAGE.

Lyophilized from a 0.2 μm filtered solution of 50 mM MOPS, 150 mM NaCl, 1 mM DTT, 1 mM EDTA, 5% Trehalose, pH 7.4 or PBS, pH 7.4, 5 mM DTT, 1mM EDTA, 8% trehalose or 20 mM His-HCl, 8% Trehalose, 2% Mannitol, 0.05% Tween 80, 1 mM EDTA, 1mM DTT, pH 6.0 or PBS, pH 7.4, 5 mM DTT, 1mM EDTA, 8% trehalose.

Room temperature in continental US; may vary elsewhere.